245 related articles for article (PubMed ID: 7740478)
1. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
[TBL] [Abstract][Full Text] [Related]
2. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
3. [Plasma level of various markers in patients with thrombotic thrombocytopenic purpura].
Wada H; Tamaki S; Shirakawa S
Rinsho Ketsueki; 1994 Apr; 35(4):346-51. PubMed ID: 8028179
[TBL] [Abstract][Full Text] [Related]
4. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
5. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.
Quintini G; Barbera V; Iannitto E; Spadola V; Fadda R; Greco G; Mazzola G; Mariani G
Transfus Apher Sci; 2003 Oct; 29(2):141-5. PubMed ID: 12941352
[TBL] [Abstract][Full Text] [Related]
10. Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
Vianelli N; Catani L; Gugliotta L; Nocentini F; Baravelli S; Lancellotti G; Tura S
Haematologica; 1996; 81(1):3-7. PubMed ID: 8900845
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
[TBL] [Abstract][Full Text] [Related]
12. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
13. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
15. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
16. [Cytokine levels in patients with thrombotic thrombocytopenic purpura].
Wada H; Minami N; Shirakawa S
Nihon Rinsho; 1993 Jan; 51(1):151-4. PubMed ID: 7679449
[TBL] [Abstract][Full Text] [Related]
17. [Thrombotic thrombocytopenic purpura which was effectively treated by plasma exchange therapy--involvement of vWF and endothelial cell injury].
Tanaka H; Kusumi S; Takemoto M; Maehama S; Fujimura K; Kuramoto A; Ninomiya M; Morio K; Okuhara T
Rinsho Ketsueki; 1989 Dec; 30(12):2205-9. PubMed ID: 2621804
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
19. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
20. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
